These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27363332)

  • 1. Structural differences between amyloid beta oligomers.
    Breydo L; Kurouski D; Rasool S; Milton S; Wu JW; Uversky VN; Lednev IK; Glabe CG
    Biochem Biophys Res Commun; 2016 Sep; 477(4):700-705. PubMed ID: 27363332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Aβ peptide forms non-amyloid fibrils in the presence of carbon nanotubes.
    Luo J; Wärmländer SK; Yu CH; Muhammad K; Gräslund A; Pieter Abrahams J
    Nanoscale; 2014 Jun; 6(12):6720-6. PubMed ID: 24820873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solvent exposure of Tyr10 as a probe of structural differences between monomeric and aggregated forms of the amyloid-β peptide.
    Aran Terol P; Kumita JR; Hook SC; Dobson CM; Esbjörner EK
    Biochem Biophys Res Commun; 2015 Dec; 468(4):696-701. PubMed ID: 26551456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elongation affinity, activation barrier, and stability of Aβ42 oligomers/fibrils in physiological saline.
    Rodriguez RA; Chen LY; Plascencia-Villa G; Perry G
    Biochem Biophys Res Commun; 2017 May; 487(2):444-449. PubMed ID: 28427941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating Conformationally Distinct Alzheimer's Amyloid-β Oligomers Using Liquid Crystals.
    Pani I; Madhu P; Najiya N; Aayush A; Mukhopadhyay S; Pal SK
    J Phys Chem Lett; 2020 Nov; 11(21):9012-9018. PubMed ID: 33040538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new structural model of Aβ40 fibrils.
    Bertini I; Gonnelli L; Luchinat C; Mao J; Nesi A
    J Am Chem Soc; 2011 Oct; 133(40):16013-22. PubMed ID: 21882806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution.
    Klinger AL; Kiselar J; Ilchenko S; Komatsu H; Chance MR; Axelsen PH
    Biochemistry; 2014 Dec; 53(49):7724-34. PubMed ID: 25382225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
    J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine inhibits β-amyloid aggregation and disassembles preformed β-amyloid aggregates.
    Takahashi-Ito K; Makino M; Okado K; Tomita T
    Biochem Biophys Res Commun; 2017 Nov; 493(1):158-163. PubMed ID: 28917837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation.
    Wu JW; Breydo L; Isas JM; Lee J; Kuznetsov YG; Langen R; Glabe C
    J Biol Chem; 2010 Feb; 285(9):6071-9. PubMed ID: 20018889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous dimer states of the Aβ(21-30) decapeptide.
    Smith MD; Srinivasa Rao J; Cruz L
    Phys Chem Chem Phys; 2014 Jul; 16(26):13069-73. PubMed ID: 24888358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of Alzheimer's Abeta17-42 (p3) oligomers: the importance of the turn location and its conformation.
    Miller Y; Ma B; Nussinov R
    Biophys J; 2009 Aug; 97(4):1168-77. PubMed ID: 19686665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
    Gu L; Guo Z
    Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
    Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
    J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).
    Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK
    Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tip-Enhanced Raman Spectroscopy to Distinguish Toxic Oligomers from Aβ
    Bonhommeau S; Talaga D; Hunel J; Cullin C; Lecomte S
    Angew Chem Int Ed Engl; 2017 Feb; 56(7):1771-1774. PubMed ID: 28071842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.